Hemodynamic effects of petrinitrol in man

Area of Science:

• Cardiology
• Pharmacology

Background:

• Angina pectoris is a common cardiovascular condition.
• Existing antianginal agents have limitations.
• Novel therapeutic agents are needed to manage angina.

Purpose of the Study:

• To evaluate the hemodynamic effects of petrinitrol, a novel antianginal agent.
• To compare the effects of different petrinitrol dosages and administration routes.
• To assess the duration and magnitude of petrinitrol's cardiovascular impact.

Main Methods:

• Cardiac catheterization was performed on 30 patients.
• Petrinitrol was administered at 5 mg and 10 mg doses, both sublingually and orally.
• Hemodynamic parameters including systemic arterial pressure, cardiac index, stroke index, and pulmonary arterial pressure were measured.

Main Results:

• Both 5 mg and 10 mg doses of petrinitrol significantly reduced systemic arterial pressure, cardiac index, stroke index, and pulmonary arterial pressure.
• These reductions were most prominent 15 to 30 minutes post-administration.
• The 10 mg sublingual dose also significantly reduced left ventricular work, with effects greater in magnitude and duration than nitroglycerin.

Conclusions:

• Petrinitrol demonstrates significant hemodynamic effects beneficial for antianginal therapy.
• The drug exhibits a dose-dependent and route-dependent hemodynamic profile.
• Petrinitrol shows potential as an effective antianginal agent with a more pronounced and sustained action compared to nitroglycerin.